Evidence map›Paper›PMID 34517166›Full record

Observational studyClinical neurology and neurosurgery2021

Trends in interventional stroke device utilization during the COVID-19 pandemic.

Arjun Rohit Adapa, Mouhammad A Jumaa, Fazeel M Siddiqui, Giana Dawod, Osama O Zaidat, Hitinder S Gurm, Aditya S Pandey

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Clinical neurology and neurosurgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Device use trends in neuroendovascular procedures in the United States from 2015 to 2020.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Arjun Rohit AdapaSchool of Medicine, University of Michigan, Ann Arbor, MI, USA.
Mouhammad A JumaaProMedica Neurosciences Institute, Toledo, OH, USA; Department of Neurology, University of Toledo, Toledo, OH, USA.
Fazeel M SiddiquiMetro Health, University of Michigan, Wyoming, MI, USA.
Giana DawodCollege of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA.
Osama O ZaidatNeuroscience Department, Bon Secours Mercy Health St. Vincent Medical Center, Toledo, OH, USA.
Hitinder S GurmDivision of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Aditya S PandeyDepartment of Neurosurgery, University of Michigan, Ann Arbor, MI, USA. Electronic address: adityap@med.umich.edu.
University of Michigan · USMichigan Medicine · USNeurosciences Institute · USSt Vincent Medical Center · USUniversity of Toledo · US

Funding

Novel Cilia Trafficking MechanismsR01DK084725 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARGOLIS, BENJAMIN L · 2009 to 2010
$702k
NIDDK NIH HHS R01 DK084725
6 · The paper itself

Abstract

objectivesThe collateral effect of the COVID-19 pandemic on interventional stroke care is not well described. We studied this effect by utilizing stroke device sales data as markers of interventional stroke case volume in the United States.

methodsUsing a real-time healthcare device sales registry, this observational study examined trends in the sales of thrombectomy devices and cerebral aneurysm coiling from the same 945 reporting hospitals in the U.S. between January 22 and June 31, 2020, and for the same months in 2018 and 2019 to allow for comparison. We simultaneously reviewed daily reports of new COVID-19 cases. The strength of association between the cumulative incidence of COVID-19 and procedural device sales was measured using Spearman rank correlation coefficient (CC).

resultsDevice sales decreased for thrombectomy (- 3.7%) and cerebral aneurysm coiling (- 8.5%) when comparing 2019-2020. In 2020, thrombectomy device sales were negatively associated with the cumulative incidence of COVID-19 (CC - 0.56, p < 0.0001), with stronger negative correlation during April (CC - 0.97, p < 0.0001). The same negative correlation was observed with aneurysm treatment devices (CC - 0.60, p < 0.001), with stronger correlation in April (CC - 0.97, p < 0.0001).

conclusionsThe decline in sales of stroke interventional equipment underscores a decline in associated case volumes. Future pandemic responses should consider strategies to mitigate such negative collateral effects.

Indexed as

CommerceCOVID-19HumansIntracranial AneurysmPandemicsStrokeThrombectomyUnited StatesVascular Access DevicesAneurysmCOVID-19Device salesSubarachnoid hemorrhageThrombectomy

Identifiers

PMID34517166
PMCPMC8411657
OpenAlexW3198079600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.